Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

EPIGENETIC TARGETING OF ADIPOCYTES INHIBITS HIGH-GRADE SEROUS OVARIAN CANCER CELL MIGRATION AND INVASION.

Tang J, Pulliam N, Ozes A, Buechlein A, Ding N, Rusch D, Keer H, O'Hagan H, Stack MS, Nephew KP.

Mol Cancer Res. 2018 May 14. pii: molcanres.0406.2017. doi: 10.1158/1541-7786.MCR-17-0406. [Epub ahead of print]

PMID:
29759990
2.

Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue.

Loughran EA, Leonard AK, Hilliard TS, Phan RC, Yemc MG, Harper E, Sheedy E, Klymenko Y, Asem M, Liu Y, Yang J, Johnson J, Tarwater L, Shi Z, Leevy M, Ravosa MJ, Stack MS.

Neoplasia. 2018 May 10;20(6):621-631. doi: 10.1016/j.neo.2018.03.007. [Epub ahead of print]

3.

RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.

Shi Z, Li C, Tarwater L, Li J, Li Y, Kaliney W, Chandrashekar DS, Stack MS.

J Oncol. 2018 Feb 14;2018:2439527. doi: 10.1155/2018/2439527. eCollection 2018.

4.

Methods for the visualization and analysis of extracellular matrix protein structure and degradation.

Leonard AK, Loughran EA, Klymenko Y, Liu Y, Kim O, Asem M, McAbee K, Ravosa MJ, Stack MS.

Methods Cell Biol. 2018;143:79-95. doi: 10.1016/bs.mcb.2017.08.005.

PMID:
29310793
5.

Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis.

Feist PE, Loughran EA, Stack MS, Hummon AB.

Anal Bioanal Chem. 2018 Feb;410(5):1583-1594. doi: 10.1007/s00216-017-0813-9. Epub 2017 Dec 27.

PMID:
29282499
6.

Chemical Analysis of Morphological Changes in Lysophosphatidic Acid-Treated Ovarian Cancer Cells.

Bailey KA, Klymenko Y, Feist PE, Hummon AB, Stack MS, Schultz ZD.

Sci Rep. 2017 Nov 10;7(1):15295. doi: 10.1038/s41598-017-15547-7.

7.

Multiparity activates interferon pathways in peritoneal adipose tissue and decreases susceptibility to ovarian cancer metastasis in a murine allograft model.

Loughran EA, Phan RC, Leonard AK, Tarwater L, Asem M, Liu Y, Yang J, Klymenko Y, Johnson J, Shi Z, Hilliard TS, Blumenthaler M, Leevy M, Ravosa MJ, Stack MS.

Cancer Lett. 2017 Dec 28;411:74-81. doi: 10.1016/j.canlet.2017.09.028. Epub 2017 Sep 28.

PMID:
28964786
8.

Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® System.

Sutton BC, Birse RT, Maggert K, Ray T, Hobbs J, Ezenekwe A, Kazmierczak J, Mosko M, Kish J, Bullock A, Shi Z, Stack MS, Irwin D.

PLoS One. 2017 Sep 19;12(9):e0183715. doi: 10.1371/journal.pone.0183715. eCollection 2017.

9.

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.

Sawe RT, Mining SK, Ofulla AV, Patel K, Guyah B, Chumba D, Prosperi JR, Kerper M, Shi Z, Sandoval-Cooper M, Taylor K, Badve S, Stack MS, Littlepage LE.

Trop Med Health. 2017 Aug 4;45:19. doi: 10.1186/s41182-017-0059-4. eCollection 2017.

10.

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.

Klymenko Y, Kim O, Stack MS.

Cancers (Basel). 2017 Aug 9;9(8). pii: E104. doi: 10.3390/cancers9080104. Review.

11.

Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.

Yang J, Kasberg WC, Celo A, Liang Z, Quispe K, Stack MS.

J Biol Chem. 2017 Aug 11;292(32):13111-13121. doi: 10.1074/jbc.M117.800904. Epub 2017 Jun 27.

PMID:
28655772
12.

Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.

Klymenko Y, Kim O, Loughran E, Yang J, Lombard R, Alber M, Stack MS.

Oncogene. 2017 Oct 19;36(42):5840-5851. doi: 10.1038/onc.2017.171. Epub 2017 Jun 19.

13.

Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.

Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E, Stack MS.

Neoplasia. 2017 Jul;19(7):549-563. doi: 10.1016/j.neo.2017.04.002. Epub 2017 Jun 9.

14.

Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.

Shah SS, Senapati S, Klacsmann F, Miller DL, Johnson JJ, Chang HC, Stack MS.

Cancers (Basel). 2016 Sep 9;8(9). pii: E85. doi: 10.3390/cancers8090085. Review.

15.

Wnt5a Signaling in Cancer.

Asem MS, Buechler S, Wates RB, Miller DL, Stack MS.

Cancers (Basel). 2016 Aug 26;8(9). pii: E79. doi: 10.3390/cancers8090079. Review.

16.

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis.

Lewellen KA, Metzinger MN, Liu Y, Stack MS.

J Vis Exp. 2016 Jul 18;(113). doi: 10.3791/53316.

PMID:
27500635
17.

Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration.

Sawe RT, Kerper M, Badve S, Li J, Sandoval-Cooper M, Xie J, Shi Z, Patel K, Chumba D, Ofulla A, Prosperi J, Taylor K, Stack MS, Mining S, Littlepage LE.

BMC Cancer. 2016 Mar 10;16:204. doi: 10.1186/s12885-016-2204-6.

18.

Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells.

Bruney L, Liu Y, Grisoli A, Ravosa MJ, Stack MS.

Oncotarget. 2016 Apr 19;7(16):21968-81. doi: 10.18632/oncotarget.7880.

19.

Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.

Johnson JJ, Miller DL, Jiang R, Liu Y, Shi Z, Tarwater L, Williams R, Balsara R, Sauter ER, Stack MS.

J Biol Chem. 2016 Mar 25;291(13):6936-45. doi: 10.1074/jbc.M115.692640. Epub 2016 Feb 2.

20.

Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.

Liu Y, Metzinger MN, Lewellen KA, Cripps SN, Carey KD, Harper EI, Shi Z, Tarwater L, Grisoli A, Lee E, Slusarz A, Yang J, Loughran EA, Conley K, Johnson JJ, Klymenko Y, Bruney L, Liang Z, Dovichi NJ, Cheatham B, Leevy WM, Stack MS.

Cancer Res. 2015 Dec 1;75(23):5046-57. doi: 10.1158/0008-5472.CAN-15-0706. Epub 2015 Nov 16.

21.

Integrated, DC voltage-driven nucleic acid diagnostic platform for real sample analysis: Detection of oral cancer.

Slouka Z, Senapati S, Shah S, Lawler R, Shi Z, Stack MS, Chang HC.

Talanta. 2015 Dec 1;145:35-42. doi: 10.1016/j.talanta.2015.04.083. Epub 2015 May 6.

22.

Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.

Burkhalter RJ, Westfall SD, Liu Y, Stack MS.

J Biol Chem. 2015 Sep 4;290(36):22143-54. doi: 10.1074/jbc.M115.641092. Epub 2015 Jul 14.

23.

Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.

Shi Z, Johnson JJ, Jiang R, Liu Y, Stack MS.

Arch Oral Biol. 2015 Sep;60(9):1416-27. doi: 10.1016/j.archoralbio.2015.06.007. Epub 2015 Jun 20.

24.

Nanoparticle analysis of cancer cells by light transmission spectroscopy.

Sun N, Johnson J, Stack MS, Szajko J, Sander C, Rebuyon R, Deatsch A, Easton J, Tanner CE, Ruggiero ST.

Anal Biochem. 2015 Sep 1;484:58-65. doi: 10.1016/j.ab.2015.05.004. Epub 2015 May 14.

PMID:
25981981
25.

Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.

Miller DL, Davis JW, Taylor KH, Johnson J, Shi Z, Williams R, Atasoy U, Lewis JS Jr, Stack MS.

Am J Pathol. 2015 Mar;185(3):679-92. doi: 10.1016/j.ajpath.2014.11.018. Epub 2015 Jan 5.

26.

Correlation of X-ray computed tomography with quantitative nuclear magnetic resonance methods for pre-clinical measurement of adipose and lean tissues in living mice.

Metzinger MN, Miramontes B, Zhou P, Liu Y, Chapman S, Sun L, Sasser TA, Duffield GE, Stack MS, Leevy WM.

Sensors (Basel). 2014 Oct 8;14(10):18526-42. doi: 10.3390/s141018526.

27.
28.

An ion-exchange nanomembrane sensor for detection of nucleic acids using a surface charge inversion phenomenon.

Senapati S, Slouka Z, Shah SS, Behura SK, Shi Z, Stack MS, Severson DW, Chang HC.

Biosens Bioelectron. 2014 Oct 15;60:92-100. doi: 10.1016/j.bios.2014.04.008. Epub 2014 Apr 13.

29.

Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.

Johnson J, Shi Z, Liu Y, Stack MS.

Oral Oncol. 2014 May;50(5):468-77. doi: 10.1016/j.oraloncology.2014.02.004. Epub 2014 Feb 28.

30.

Detecting microRNA in human cancer tissues with fluorescence in situ hybridization.

Shi Z, Johnson JJ, Stack MS.

Methods Mol Biol. 2013;1039:19-27. doi: 10.1007/978-1-62703-535-4_2.

PMID:
24026683
31.

Epithelial ovarian cancer experimental models.

Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS.

Oncogene. 2014 Jul 10;33(28):3619-33. doi: 10.1038/onc.2013.321. Epub 2013 Aug 12. Review.

32.

Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Barbolina MV, Liu Y, Gurler H, Kim M, Kajdacsy-Balla AA, Rooper L, Shepard J, Weiss M, Shea LD, Penzes P, Ravosa MJ, Stack MS.

J Biol Chem. 2013 Jan 4;288(1):141-51. doi: 10.1074/jbc.M112.431411. Epub 2012 Nov 14.

33.

Fluorescence In Situ Hybridization for MicroRNA Detection in Archived Oral Cancer Tissues.

Shi Z, Johnson JJ, Stack MS.

J Oncol. 2012;2012:903581. doi: 10.1155/2012/903581. Epub 2012 May 13.

34.

Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.

Liu Y, Burkhalter R, Symowicz J, Chaffin K, Ellerbroek S, Stack MS.

J Oncol. 2012;2012:501492. doi: 10.1155/2012/501492. Epub 2012 Apr 22.

35.

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.

Miller DL, Puricelli MD, Stack MS.

Biochem J. 2012 Apr 15;443(2):339-53. doi: 10.1042/BJ20112017. Review.

36.

The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA, Hooper JD.

J Biol Chem. 2012 Mar 23;287(13):9792-803. doi: 10.1074/jbc.M111.335448. Epub 2012 Feb 7.

37.

Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.

Rodriguez GC, Turbov JM, Berchuck A, Stack MS, Hurteau JA, Thaete LG, Barry CP.

Am J Obstet Gynecol. 2012 Mar;206(3):253.e1-9. doi: 10.1016/j.ajog.2011.11.012. Epub 2011 Nov 25.

PMID:
22206747
38.

Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.

Barbolina MV, Burkhalter RJ, Stack MS.

Biochem J. 2011 Jul 1;437(1):1-12. doi: 10.1042/BJ20110112. Review.

39.

Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.

Shi Z, Liu Y, Johnson JJ, Stack MS.

Mol Cell Biochem. 2011 Nov;357(1-2):151-61. doi: 10.1007/s11010-011-0885-3. Epub 2011 Jun 1.

PMID:
21630091
40.

Integrin regulation of beta-catenin signaling in ovarian carcinoma.

Burkhalter RJ, Symowicz J, Hudson LG, Gottardi CJ, Stack MS.

J Biol Chem. 2011 Jul 1;286(26):23467-75. doi: 10.1074/jbc.M110.199539. Epub 2011 Apr 25.

41.

Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.

Jiang R, Shi Z, Johnson JJ, Liu Y, Stack MS.

J Biol Chem. 2011 Mar 18;286(11):9127-35. doi: 10.1074/jbc.M110.191361. Epub 2010 Dec 16.

42.

Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts.

Ravosa MJ, Ning J, Liu Y, Stack MS.

Arch Oral Biol. 2011 May;56(5):491-8. doi: 10.1016/j.archoralbio.2010.11.003. Epub 2010 Dec 10.

PMID:
21146154
43.

Molecules of cell adhesion and extracellular matrix proteolysis in oral squamous cell carcinoma.

Shi Z, Stack MS.

Histol Histopathol. 2010 Jul;25(7):917-32. doi: 10.14670/HH-25.917. Review.

PMID:
20503180
44.

Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma.

Barbolina MV, Kim M, Liu Y, Shepard J, Belmadani A, Miller RJ, Shea LD, Stack MS.

Mol Cancer Res. 2010 May;8(5):653-64. doi: 10.1158/1541-7786.MCR-09-0463. Epub 2010 May 11.

45.

Masticatory loading, function, and plasticity: a microanatomical analysis of mammalian circumorbital soft-tissue structures.

Jasarević E, Ning J, Daniel AN, Menegaz RA, Johnson JJ, Stack MS, Ravosa MJ.

Anat Rec (Hoboken). 2010 Apr;293(4):642-50. doi: 10.1002/ar.21135.

46.

Masticatory biomechanics and masseter fiber-type plasticity.

Ravosa MJ, Ning J, Costley DB, Daniel AN, Stock SR, Stack MS.

J Musculoskelet Neuronal Interact. 2010 Mar;10(1):46-55.

47.

Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.

Ghosh S, Koblinski J, Johnson J, Liu Y, Ericsson A, Davis JW, Shi Z, Ravosa MJ, Crawford S, Frazier S, Stack MS.

Mol Cancer Res. 2010 Feb;8(2):145-58. doi: 10.1158/1541-7786.MCR-09-0045. Epub 2010 Feb 9.

48.

Targeting the EGF receptor for ovarian cancer therapy.

Zeineldin R, Muller CY, Stack MS, Hudson LG.

J Oncol. 2010;2010:414676. doi: 10.1155/2010/414676. Epub 2009 Dec 28.

49.

Microenvironmental regulation of ovarian cancer metastasis.

Barbolina MV, Moss NM, Westfall SD, Liu Y, Burkhalter RJ, Marga F, Forgacs G, Hudson LG, Stack MS.

Cancer Treat Res. 2009;149:319-34. doi: 10.1007/978-0-387-98094-2_15. Review. No abstract available.

PMID:
19763443
50.

Activated epidermal growth factor receptor in ovarian cancer.

Hudson LG, Zeineldin R, Silberberg M, Stack MS.

Cancer Treat Res. 2009;149:203-26. doi: 10.1007/978-0-387-98094-2_10. Review. No abstract available.

Supplemental Content

Loading ...
Support Center